There were 1,741 press releases posted in the last 24 hours and 426,723 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image